Establishment Of The Evaluation Model Of Success Factors Of Large Variety Of Chinese Patent Medicine In H Company

In recent years,with the rapid rise of large varieties of Chinese patent medicine,the industrial development of Chinese medicine industry has been promoted,and the influence of Chinese medicine industry in the pharmaceutical industry has been increasing.Presently,a "new normal" has occurred under the China’s economic development.The growth rate of economic has changed from high speed to medium speed.In this context,the Chinese medicine industry is in the throes of structural adjustment.As the engine of the development of the Chinese medicine industry,the cultivation of large varieties with value regression as the core is of particular importance.In this paper,H company which is a Chinese patent medicine platform of the central enterprise and a-share listed company was taken as the research object.Through the analysis of the external environment and internal environment of H company,the strategy of the company to develop large varieties of cardiac and cerebrovascular and anti-tumor Chinese patent medicine was determined.Five indicators of policy qualification,clinical value,marketing,technical barriers and industrial chain ecology were determined through the analysis of commercial canvas.The above 5 indicators were decomposed through questionnaire survey,and 65 indicators were collected to form large varieties of Chinese patent medicine.By means of expert interview,the index screening was carried out,and finally 57 indicators were determined,and a three-level index system of success factors of Chinese patent medicine varieties was established,including 5 first-level indicators,15 second-level indicators and 37 third-level indicators.By empirical analysis method,through analysis the mainstream proprietary Chinese medicine enterprise success or failure case,build the model,the factors of success to determine the index weight,policy qualification 15%respectively(health care and medicine 20%,50%,a path with a guide price and bidding.30%),the clinical value of 20%(clinical uniqueness,60%to 20%,20%)clinical scientific and marketing 30%(30%30%market planning,product/brand construction,the promotion 40%),technical barriers to 30%(research and development strength by 60%,20%quality control,20%of upgrading and innovation)and 5%of the industrial chain(30%of the ecosystem integrity,30%of the ecosystem synergy,40%of the ecosystem competitiveness);Finally,the improvement direction of H company was determined according to the self-built model,and the strategic implementation plan and risk control measures were formulated.In this paper,the evaluation model of success factors of Chinese patent medicine great variety was established,and the practical path of H company’s strategy of Chinese patent medicine great variety was established.The research achievements of this paper has strong promotion value and commercial value,and foster proprietary Chinese medicine Chinese medicine enterprises large variety of beneficial exploration in the field of traditional Chinese medicine(TCM)is the first system research content of this report,the enterprise strategy formulation,implementation and feedback to each link of scientific,commercial research and demonstration,provide case reference for proprietary Chinese medicine enterprise strategy formulation.